Form S-1/A Elevation Oncology, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Elevation Oncology (ELEV) Files 6.25M Share IPO at $15-$17/sh
June 23, 2021 3:42 PM EDTElevation Oncology (NASDAQ: ELEV) has filed to IPO 6.25M shares at $15-$17 per share.
ELEV is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. It is focused on identifying... More
